Rapid Micro Biosystems (RPID) Change in Accured Expenses (2020 - 2026)

Rapid Micro Biosystems has disclosed Change in Accured Expenses across 7 years of filings, most recently posting -$2.2 million for Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$2.2 million, down 11.43% year-over-year; the trailing twelve-month figure through Mar 2026 was -$201000.0 (up 92.82% YoY), and the FY2025 annual result was $28000.0, up 100.72% from the prior year.
• Change in Accured Expenses came in at -$2.2 million for Q1 2026 at Rapid Micro Biosystems, down from $1.1 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $2.9 million in Q4 2023 to a low of -$3.9 million in Q1 2022.
• The 5-year median for Change in Accured Expenses is -$439000.0 (2024), against an average of -$436470.6.
• Across the five-year window, Change in Accured Expenses plunged 396.8% in 2022 and jumped 28860.0% in 2023, its largest moves.
• Rapid Micro Biosystems' Change in Accured Expenses stood at $10000.0 in 2022, then surged by 28860.0% to $2.9 million in 2023, then sank by 115.16% to -$439000.0 in 2024, then surged by 349.89% to $1.1 million in 2025, then sank by 303.46% to -$2.2 million in 2026.
• The last three Change in Accured Expenses figures came in at -$2.2 million (Q1 2026), $1.1 million (Q4 2025), and $599000.0 (Q3 2025), per Business Quant data.